[The influences of prostaglandin E2 on hormones in maternal-fetoplacental unit]. 1984

I Miyakawa, and K Taniyama, and C H Lee, and M Azegami, and N Mori

The influences of PGE2 on hormones in maternal-fetoplacental unit and the initiation of labor were studied in full term pregnant women. PGE 2 (500 micrograms, 1tab.) was administered every hour, 6 times and serum unconjugated estriol (E3), progesterone (P), human placental lactogen (hPL), prolactin (Prl) and cortisol (C) were assayed before and during PGE2 administration. In 13 pregnant women (Group A) in whom uterine contractions were induced, E3, hPL and C were higher, though not significantly, than those in 6 women (Group B) in whom uterine contractions did not occur. On the other hand the P level in Group A was lower than in Group B. E3 levels during PGE2 administration rose slightly in both groups. P decreased 16.8% of basal levels in Group A, 7.3% in Group B. Prl decreases were 11.7% and 24.8%, respectively. These drops were not as significant as the changes in hPL and C. These results suggest that the method and dosage of PGE2 used in this study do not affect hormonal regulations in the maternal-fetoplacental unit and that we may use hormonal levels as an indicator of fetal well-being even during PGE2 administration.

UI MeSH Term Description Entries
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D010928 Placental Lactogen A polypeptide hormone of approximately 25 kDa that is produced by the SYNCYTIOTROPHOBLASTS of the PLACENTA, also known as chorionic somatomammotropin. It has both GROWTH HORMONE and PROLACTIN activities on growth, lactation, and luteal steroid production. In women, placental lactogen secretion begins soon after implantation and increases to 1 g or more a day in late pregnancy. Placental lactogen is also an insulin antagonist. Choriomammotropin,Chorionic Somatomammotropin, Human,Human Placental Lactogen,Lactogen Hormone, Placental,Mammotropic Hormone, Placental,Somatomammotropin, Chorionic,Choriomammotrophin,HCS (Human Chorionic Somatomammotropin),HPL (Human Placental Lactogen),PAPP-D,Placental Luteotropin,Pregnancy-Associated Plasma Protein D,Chorionic Somatomammotropin,Human Chorionic Somatomammotropin,Lactogen, Placental,Luteotropin, Placental,Placental Lactogen, Human,Placental Mammotropic Hormone,Pregnancy Associated Plasma Protein D
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004964 Estriol A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, a large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol. (16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,(16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,16-alpha-Hydroxy-Estradiol,16alpha,17beta-Estriol,16beta-Hydroxy-Estradiol,Epiestriol,Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol,Ovestin,16 alpha Hydroxy Estradiol,16alpha,17beta Estriol,16beta Hydroxy Estradiol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

I Miyakawa, and K Taniyama, and C H Lee, and M Azegami, and N Mori
October 1976, British journal of obstetrics and gynaecology,
I Miyakawa, and K Taniyama, and C H Lee, and M Azegami, and N Mori
November 1984, Nihon rinsho. Japanese journal of clinical medicine,
I Miyakawa, and K Taniyama, and C H Lee, and M Azegami, and N Mori
November 2022, Molecular reproduction and development,
I Miyakawa, and K Taniyama, and C H Lee, and M Azegami, and N Mori
July 1979, Archives of gynecology,
I Miyakawa, and K Taniyama, and C H Lee, and M Azegami, and N Mori
September 1970, Clinical obstetrics and gynecology,
I Miyakawa, and K Taniyama, and C H Lee, and M Azegami, and N Mori
January 1972, Duodecim; laaketieteellinen aikakauskirja,
I Miyakawa, and K Taniyama, and C H Lee, and M Azegami, and N Mori
October 1985, Biology of reproduction,
I Miyakawa, and K Taniyama, and C H Lee, and M Azegami, and N Mori
September 1976, The American journal of physiology,
I Miyakawa, and K Taniyama, and C H Lee, and M Azegami, and N Mori
January 1996, Biology of the neonate,
I Miyakawa, and K Taniyama, and C H Lee, and M Azegami, and N Mori
November 1983, Experimental and clinical endocrinology,
Copied contents to your clipboard!